Douglas Gladstone

Associate Professor

19992019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Douglas Gladstone is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 34 Similar Profiles
Cyclophosphamide Medicine & Life Sciences
Transplantation Medicine & Life Sciences
Bone Marrow Transplantation Medicine & Life Sciences
Graft vs Host Disease Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Tissue Donors Medicine & Life Sciences
Transplants Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study

Strati, P., Fanale, M. A., Oki, Y., Turturro, F., Fayad, L. E., Bartlett, N. L., Gladstone, D., Kasamon, Y. L., Portlock, C. S., Wilson, W. H., Goy, A., Younes, A. & Lee, H. J., Feb 1 2019, In : Haematologica. 104, 2, p. e65-e67

Research output: Contribution to journalLetter

Hodgkin Disease
Rituximab

Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction

Hambley, B. C., Norsworthy, K. J., Jasem, J., Zimmerman, J. W., Shenderov, E., Webster, J., Showel, M., Gondek, L., Dalton, W., Prince, G., Gladstone, D., Streiff, M. B., Pratz, K., Gojo, I., Ghiaur, G., Levis, M. J., Smith, B. D. & Dezern, A., Aug 1 2019, In : Leukemia Research. 83, 106174.

Research output: Contribution to journalLetter

Acute Promyelocytic Leukemia
Fibrinogen
Heparin
Hemorrhage
Bone Marrow Transplantation
Fever
Transplants
Unrelated Donors
Cyclophosphamide